Organization
Hikma Pharmaceuticals Plc
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Hikma Pharmaceuticals Plc
... London - Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's ...
... years, culminating in his nomination to the position of CEO of Roche Pharmaceuticals and board seats at Roche, Genentech and Chugai Pharmaceuticals. Since 2010, he ...
... GSK's top-selling asthma drug Advair that it is developing with US firm Hikma, was knocked back by regulators in the States. The duo are hoping ...
... years, culminating in his nomination to the position of CEO of Roche Pharmaceuticals and board seats at Roche, Genentech and Chugai Pharmaceuticals. Since 2010, he ...
... market with some of the key players being Hospira (Pfizer), Fresenius Kabi, Hikma, Sandoz (Novartis), Sagent, Sanofi and Baxter. Key Topics Covered: 1 Preface 2 ...
... London - Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), the fast growing ...
... Hikma Pharmaceuticals Plc's U.S. subsidiary has raised the price of a common diarrhea drug ...
... doesn’t mean prices on some unusual formulas aren’t going up. Just ask Hikma Pharmaceuticals, which posted a half-dozen big price rises just this month. The ...
... inhaled airways products, today confirms the statement made by its partner Hikma Pharmaceuticals PLC ('Hikma') in its interim results statement in respect of its abbreviated ...
... London - Hikma Pharmaceuticals PLC (Hikma, Group) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY) (rated Ba1 ...
... HIKMA Pharmaceuticals' shares fell 10.5pc after the drug maker lowered its forecast sales ...
... HIKMA Pharmaceuticals yesterday announced it expects revenue to come in at the lower ...
... Hikma PharmaceuticalsPLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), the fast growing ...
... LONDON, UK - Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's ...
... its drug for narcolepsy patients. The drugmaker inked a patent settlement with Hikma Pharma earlier this year, setting a launch date in 2023. That settlement, ...
... FTSE 100 alongside industrial developer Segro, while Intu Properties and drug maker Hikma have been demoted from the blue chip index, the FTSE Russell confirmed ...
... due to be confirmed later today. The companies are set to replace Hikma Pharmaceuticals and Intu Properties in the blue-chip index, indicative figures from the ...
... DRUG MAKER Hikma has cut its fullyear revenue forecasts after its plan to launch a ...
... in releasing its generic version of the blockbuster asthma drug Advair. Hikma Pharmaceuticals Plc, the London parent of the drug manufacturer, had projected that its ...
... a respective 37.5p to £16.65 and 68p to £47.51, generic drug maker Hikma Pharmaceuticals was among the laggards, with shares falling 36p to £17.59. That ...
... announces that its partner on VR315 US (generic Advair Diskus programme), Hikma Pharmaceuticals PLC ('Hikma') has confirmed it has received a Complete Response Letter ('CRL') ...
... while Berenberg downgraded National Grid to "hold". Other laggards included pharma stocks Hikma and Vectura, which spent a second consecutive trading session in the doldrums. ...
... after the Bank of England downgraded UK growth prospects. Jordanian pharmaceuticals firm Hikma was the biggest drag on the index after it found itself on ...
... 8.23% @courtneynoelg HIKMA Pharmaceuticals' shares fell almost nine per cent yesterday after its asthma drug's ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤